Thursday, 30 Apr 2026
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • ScienceAlert
  • White
  • VIDEO
  • man
  • Trumps
  • Season
  • star
  • Years
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Politics > Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About |
Politics

Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About |

Last updated: May 8, 2025 2:10 pm
Share
Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About |
SHARE

(Note: We appreciate your support for businesses like the one featured in the sponsored message below. Your engagement with them through the provided links benefits Gateway Pundit. Thank you!)

The COVID-19 pandemic served as a stark revelation for millions of Americans regarding the priorities of the medical establishment. Instead of prioritizing public health, we witnessed a troubling alignment with the profit motives of the biopharmaceutical industry.

This phenomenon of greed is not merely a byproduct of pandemic responses; it permeates the entire healthcare system, often dictating the actions of our medical establishment in addressing various health crises.

One glaring example of this is evident in the ongoing battle against cancer:

A recent investigation published in the journal Cancer examined the financial implications of cancer drug pricing on pharmaceutical revenues. Dr. Daniel Meyers from the University of Calgary and his team analyzed revenue trends from ten major pharmaceutical firms between 2010 and 2019, contrasting earnings from cancer and non-cancer medications.

The findings revealed a troubling trend: revenue from cancer drugs surged by 70% over the decade, while non-cancer drug revenue plummeted by 18%. In 2010, cancer drugs accounted for 14% of total revenues; by 2019, this figure had escalated to 25%.

Even more concerning is the lack of correlation between drug pricing and clinical outcomes:

If these exorbitantly priced drugs were delivering significant clinical advancements, their cost might be justified. However, a study in The Lancet Oncology indicates that in the U.S., the price of cancer drugs does not align with patient outcomes. Once the cost exceeds $100,000, the effectiveness of the drug becomes moot if patients cannot afford it.

It’s hardly surprising that major pharmaceutical companies and the medical establishment show little interest in pursuing cost-effective treatment alternatives.

Fortunately, there are dedicated medical professionals like Dr. Peter McCullough who are focused on providing healthcare solutions that are not only safe and effective but also affordable. Dr. McCullough and his team are currently investigating the potential of ivermectin in cancer treatment.

Early findings from a new study are encouraging. As highlighted by the McCullough Foundation:

The study titled “A Review of Ivermectin Use in Cancer Patients: Is it Time to Repurpose Ivermectin in Cancer Treatment?” has recently been published in the journal Acta Poloniae Pharmaceutica – Drug Research…

This comprehensive systematic review of ivermectin’s application in cancer patients suggests it is safe—even for those undergoing chemotherapy. Its diverse anticancer mechanisms observed in preclinical studies, along with anecdotal evidence of improvements, bolster its case for repurposing as a treatment option. Expedient, well-designed clinical trials are essential to fully evaluate ivermectin’s efficacy against cancer.

Moreover, ivermectin, in combination with mebendazole, shows even greater potential for treating various cancers.

Mebendazole, like ivermectin, is an anti-parasitic agent that has been utilized for a century to combat parasitic infections—an issue affecting over 60 million Americans today, according to the CDC.

Safe, Effective, and Affordable!

If you’re feeling unwell, a parasite cleanse could be beneficial for your health. Consider pure lab-tested Ivermectin + Mebendazole, combined into a single capsule by The Wellness Company.

  • Ivermectin and Mebendazole work synergistically to effectively address parasitic infections.

  • 90 Oral Capsules, each containing 25mg Ivermectin + 250mg Mebendazole, a clinically validated dosage.

  • The Gold Standard of safety and efficacy; the only medication of its type prescribed by licensed physicians and compounded by a pharmacy licensed in all 50 states.

Medication You Can Trust from a Respected Source in the USA

The medical professionals at The Wellness Company—like Dr. Peter McCullough and Dr. Kelly Victory—were at the forefront of efforts to disseminate accurate medical information during the COVID pandemic. These experts consistently demonstrated a commitment to prioritizing patient health over pharmaceutical profits.

Presently, The Wellness Company stands as the only entity in the world authorized to prescribe pure compounded Ivermectin + Mebendazole from a 50-state licensed pharmacy, available in a high-dose 90-day supply.

The Wellness Company’s Ivermectin + Mebendazole Parasite Cleanse has seen significant demand, selling out on three occasions—prompting the company to establish a stockpile to ensure availability amidst potential supply chain disruptions.

With looming threats of tariffs impacting international trade, many individuals have resorted to dubious overseas medication sources or unlicensed pharmacies. The Wellness Company proudly maintains its status as the only legitimate producer of this compounded formula in the U.S.

Visit The Wellness Company today to secure a 90-day supply of the ultimate parasite cleanse—Ivermectin + Mebendazole. Simply complete the two-minute intake questionnaire after checkout to finalize your prescription request.

What are people saying about The Wellness Company’s Ivermectin + Mebendazole:

I am thankful to have access to a potentially beneficial medication like ivermectin and mebendazole. Most importantly, I trust Dr. McCullough and The Wellness Company for providing a safe product, made here in our country. I am grateful for their commitment to protecting us with proven solutions while ensuring that what I’m ingesting is exactly what is stated on the label. – Jennifer W.

My daughter was diagnosed with uterine cancer and lung nodules that were found to be cancerous. After starting ivermectin/mebendazole two weeks ago, a recent PET scan showed a remarkable reduction in nodules. The physician had to search for a sizeable nodule to biopsy, as they had significantly shrunk. Thank you to all the doctors on this site for giving us HOPE and HEALING!!! – Helen

Click here to find out if Ivermectin and Mebendazole from The Wellness Company is suitable for you.

Note: The information presented on this website is for informational purposes only and should not be interpreted as medical advice or a substitute for professional healthcare guidance. It is your responsibility to adhere to all relevant laws, regulations, and guidelines regarding the purchase, possession, and use of prescription medications.

See also  FANTASYLAND: Pathetic Never-Trump Republicans Predict Democrats Poised for Big Comeback Win in 2028 |
TAGGED:bigCancerFightingdoesntDrugMcCulloughPharmaReveals
Share This Article
Twitter Email Copy Link Print
Previous Article Diddy Trial’s ‘Victim 3’ Never Cooperative with Feds, Never Wanted to Testify Diddy Trial’s ‘Victim 3’ Never Cooperative with Feds, Never Wanted to Testify
Next Article The Truth Behind Jean Smart’s Late Night Journey The Truth Behind Jean Smart’s Late Night Journey
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *


The reCAPTCHA verification period has expired. Please reload the page.

Popular Posts

Quinton Aaron’s Family Says ‘The Blind Side’ Actor Had a Spinal Stroke

Quinton Aaron, known for his role in "The Blind Side," is currently recovering after suffering…

January 30, 2026

Which is a better Python Web Framework

FastAPI vs Flask: Which Python framework suits your project best? This blog compares their features,…

July 10, 2025

Ralph Lauren Pre-Fall 2026 Collection

Ralph Lauren’s Pre-Fall Collection Transports Us to New MexicoIf we were in Nantucket for spring,…

December 18, 2025

Placate or retaliate? Starmer and Carney are both right on Trump

Unlock the White House Watch newsletter for free If you've been keeping up with the…

April 18, 2025

D.H.S. Agents Search Two Dorm Rooms at Columbia University

Department of Homeland Security officials conducted a search of two dorm rooms at Columbia University,…

March 14, 2025

You Might Also Like

OxyContin maker Purdue Pharma set to dissolve
Health and Wellness

OxyContin maker Purdue Pharma set to dissolve

April 30, 2026
ChatGPT Images 2.0 is a hit in India, but not a big winner elsewhere, yet
Tech and Science

ChatGPT Images 2.0 is a hit in India, but not a big winner elsewhere, yet

April 30, 2026
Trump Flat Out Threatens Disney In Effort To 86 Jimmy Kimmel
Politics

Trump Flat Out Threatens Disney In Effort To 86 Jimmy Kimmel

April 30, 2026
Hochul’s Dear Tom letter
Politics

Hochul’s Dear Tom letter

April 30, 2026
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?